Popular on EntSun
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter - 192
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet - 178
- Retirement Income Specialist Daniel Rondberg Joins Tom Hegna on the Exciting New Season of "Financial Freedom with Tom Hegna" - 144
- LIB Large-Scale Walk-In Test Chamber Full Process Delivery: MIL-STD-810H Chambers Enable Extreme Environment Testing - 131
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges - 121
- Tobu Railway Announces a Price Revision on the "NIKKO PASS All Area" and "NIKKO PASS World Heritage Area," from April 20, 2025 - 116
- Meditech International Inc. and Los Angeles Rams Continue Strategic Partnership to Enhance Athlete Performance and Recovery - 112
- Multi-Award Winning B.Slade to Debut in Las Vegas at Iconic Westgate Resort & Casino; The B.Slade Experience (BSX) — May 3, 2025 - 107
- Family Estrangement on the Rise: Therapist Offers Support, Perspective, and Community for Those Affected - 106
- Deevid.ai Unveils AI Kissing and AI Dancing Templates to Power Viral TikTok Content Creation - 106
Similar on EntSun
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Meditech International Inc. and Los Angeles Rams Continue Strategic Partnership to Enhance Athlete Performance and Recovery
- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet
- First Choice Neurology Partners with NeuroDiscovery AI to Advance Neurological Care and Research
- $4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- Large Strategic Investment from Global Medical Device Manufacturer to Support Clinics Treating Suicidal Depression and PTSD: NRx: (Stock Symbol: NRXP)
- $300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
- Dentaluxe's New Website Launch!
Provenance Bio Announces Results for Recombinant Protein Demonstrating Cell Adhesion Functionality that Can Replace Animal-Derived Proteins
EntSun News/11025936
SAN DIEGO - EntSun -- Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of function by matching the cell adhesion strength of fibronectin, providing promising scalable and sustainable protein solutions across various sectors, including pharmaceuticals.
Microbial-based systems for protein production can make proteins at large manufacturing scales, however, functional animal proteins which undergo post translational modifications (PTMs), remain challenging to these expression systems. Provenance's proprietary precision fermentation platform represents a major biotechnological achievement by enabling cost-effective, sustainable, and scalable recombinant solutions for high value markets. Moreover, and equally important, Provenance Bio's full-length hydroxylated type I collagen protein demonstrates cell adhesion properties comparable to fibronectin, a principal protein used for cell culturing in research and development and pharmaceutical production.
Key Findings:
More on EntSun News
The global market for cell adhesion proteins is rapidly expanding, driven by innovations in cell therapies, cultured meat development, biomaterials, and animal-free products. Provenance Bio's precision fermentation techniques have enabled the production of high-value recombinant collagen and gelatin at scale, positioning the company as a key player in the transition to sustainable protein solutions.
About Provenance Bio's Precision Fermentation Platform
Provenance Bio utilizes a unique compartment within the microbial host cell to produce and modify recombinant animal protein without the use of any animal products. The system enables precise and high-yielding protein expression and post-translational modifications (the addition of certain functional groups to the protein, such as hydroxylation), for the production of bioactive proteins at scale. Additionally, the platform supports product customization to meet specifications such as protein length, bloom strength, and viscosity for a wide range of applications.
About Cell Adhesion Proteins
Cell adhesion proteins, part of the extracellular matrix (ECM), are essential to cell and tissue cultures which are widely used in the life sciences and biomedical research and development. These proteins, e.g. laminin, fibronectin, and collagen are used for coating the cell culture vessels to enhance cell attachment and to stimulate differentiation, migration, structural support and cellular communication, to ultimately mimic the natural behavior of the studied cells. According to Grand View Research Report, the global cell culture protein surface coatings market was valued at USD 826.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2023 to 2030. Stem cell therapy and regenerative medicine are two major fields that are driving the industry growth. Animal derived protein sources have dominated the global industry, however ethical and religious views are driving demand for animal-free components.
More on EntSun News
About Provenance Bio
Provenance is an alternative protein company pioneering molecular biology tools for sustainable products. The company's proprietary micro-compartmentalization protein expression platform represents the future of biomanufacturing. For further information, visit: https://provenance.bio or email info@provenance.bio
Microbial-based systems for protein production can make proteins at large manufacturing scales, however, functional animal proteins which undergo post translational modifications (PTMs), remain challenging to these expression systems. Provenance's proprietary precision fermentation platform represents a major biotechnological achievement by enabling cost-effective, sustainable, and scalable recombinant solutions for high value markets. Moreover, and equally important, Provenance Bio's full-length hydroxylated type I collagen protein demonstrates cell adhesion properties comparable to fibronectin, a principal protein used for cell culturing in research and development and pharmaceutical production.
Key Findings:
- Provenance Bio's unique expression system produced hydroxylated, functional, and bioidentical collagen proteins
- Provenance's hydroxylated collagen proteins promote cell adhesion at a strength equivalent to traditionally used fibronectin in cultured human fibroblast cells
- Provenance collagen also performs head-to-head with human collagen and fibronectin when coated on tissue culture plates demonstrating similar adherence and dissociation with fibroblast cells
- Provenance Bio's collagen protein is being produced at an efficiency that will be cost competitive with animal proteins
More on EntSun News
- Big Red NOLA Publishing Boosts "Voices of Tomorrow"
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
The global market for cell adhesion proteins is rapidly expanding, driven by innovations in cell therapies, cultured meat development, biomaterials, and animal-free products. Provenance Bio's precision fermentation techniques have enabled the production of high-value recombinant collagen and gelatin at scale, positioning the company as a key player in the transition to sustainable protein solutions.
About Provenance Bio's Precision Fermentation Platform
Provenance Bio utilizes a unique compartment within the microbial host cell to produce and modify recombinant animal protein without the use of any animal products. The system enables precise and high-yielding protein expression and post-translational modifications (the addition of certain functional groups to the protein, such as hydroxylation), for the production of bioactive proteins at scale. Additionally, the platform supports product customization to meet specifications such as protein length, bloom strength, and viscosity for a wide range of applications.
About Cell Adhesion Proteins
Cell adhesion proteins, part of the extracellular matrix (ECM), are essential to cell and tissue cultures which are widely used in the life sciences and biomedical research and development. These proteins, e.g. laminin, fibronectin, and collagen are used for coating the cell culture vessels to enhance cell attachment and to stimulate differentiation, migration, structural support and cellular communication, to ultimately mimic the natural behavior of the studied cells. According to Grand View Research Report, the global cell culture protein surface coatings market was valued at USD 826.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2023 to 2030. Stem cell therapy and regenerative medicine are two major fields that are driving the industry growth. Animal derived protein sources have dominated the global industry, however ethical and religious views are driving demand for animal-free components.
More on EntSun News
- KBA Sports and 6x Entertainment Join Forces to Become Global Sports Partners
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
About Provenance Bio
Provenance is an alternative protein company pioneering molecular biology tools for sustainable products. The company's proprietary micro-compartmentalization protein expression platform represents the future of biomanufacturing. For further information, visit: https://provenance.bio or email info@provenance.bio
Source: Provenance Bio
0 Comments
Latest on EntSun News
- Jay Tapp was named Managing Director in British Columbia
- World Ballet Company's Cinderella Comes to the Weinberg Center This Fall
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- London Gala Emphasizes Trade, FDI and Ongoing Cooperation
- Sahit Muja Launches Trillion-Dollar Green Revolution with 10 Groundbreaking Cryptos
- Free and Low-Cost Dental Care Now Available in London Through the Canadian Dental Care Plan (CDCP)